Nouveaux membres

SERB

We are very pleased to welcome SERB as a member of the French-Norwegian Chamber of Commerce.

With a turnover of 80 millions euros in 2019, SERB is an independent pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases. Directly established in Belgium, France, Uk, germany, Poland and Luxembourg, the group is present in over 60 countries through a large network of over 50+ experienced distributors. Following strategic acquisitions from Tier 1 pharmaceutical companies, SERB has succeeded in building a consistent drugs portfolio focused on niiche specialty pharmaceuticals. The group has consolidated a global leading position in therapeutic areas such as Critical & Emergency Care, Diagnostic agents, Endocrinology and Neurology.

For more information about SERB, please visit their website.